Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1
Nanobodies as novel agents for disease diagnosis and therapy
Authors Siontorou CG
Received 24 July 2013
Accepted for publication 23 August 2013
Published 1 November 2013 Volume 2013:8(1) Pages 4215—4227
DOI https://doi.org/10.2147/IJN.S39428
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Christina G Siontorou
Department of Industrial Management and Technology, University of Piraeus, Piraeus, Greece
Abstract: The discovery of naturally occurring, heavy-chain only antibodies in Camelidae, and their further development into small recombinant nanobodies, presents attractive alternatives in drug delivery and imaging. Easily expressed in microorganisms and amenable to engineering, nanobody derivatives are soluble, stable, versatile, and have unique refolding capacities, reduced aggregation tendencies, and high-target binding capabilities. This review outlines the current state of the art in nanobodies, focusing on their structural features and properties, production, technology, and the potential for modulating immune functions and for targeting tumors, toxins, and microbes.
Keywords: heavy chain antibodies, nanobodies, antibody expression, molecular display, formatting
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.